The implementation of genomic newborn screening (gNBS) poses myriad ethical, legal and social implications (ELSI) that require a public health ethics framework. Policy tools are needed to aid gNBS implementers in navigating key strategic ELSI questions to optimize implementation and realize the benefits of gNBS.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
References
Stark, Z. & Scott, R. H. Genomic newborn screening for rare diseases. Nat. Rev. Genet. 24, 755–766 (2023).
Minten, T. et al. Data-driven consideration of genetic disorders for global genomic newborn screening programs. Genet. Med. 27, 101443 (2025).
Phillips, A., Siermann, M., Claesen-Bengtson, Z., Jackson, L. & Wright, C. F. What do we mean by actionability? Examining a key criterion in genomic prenatal and newborn screening. Genet. Med. 28, 101624 (2025).
Knoppers, B. M., Bonilha, A. E., Laberge, A.-M., Ahmed, A. & Newson, A. J. Genomic sequencing in newborn screening: balancing consent with the right of the asymptomatic at-risk child to be found. Eur. J. Hum. Genet. 33, 182–188 (2025).
Abbasi, M., Majdzadeh, R., Zali, A., Karimi, A. & Akrami, F. The evolution of public health ethics frameworks: systematic review of moral values and norms in public health policy. Med. Health Care Philos. 21, 387–402 (2018).
Watts, G., Otlowski, M., Banks, R. & Newson, A. J. Three ethical approaches to expanding newborn screening through genomics: a critical comparative analysis. BMC Med. Ethics 26, 167 (2025).
Horton, R. et al. Challenges of using whole genome sequencing in population newborn screening. BMJ 384, e077060 (2024).
Douglas, C. M. W., van El, C. G., Faulkner, A. & Cornel, M. C. Governing biological material at the intersection of care and research: the use of dried blood spots for biobanking. Croat. Med. J. 53, 390–397 (2012).
Lewis, M. H., Goldenberg, A., Anderson, R., Rothwell, E. & Botkin, J. State laws regarding the retention and use of residual newborn screening blood samples. Pediatrics 127, 703–712 (2011).
Brown, G. et al. Genomic newborn screening: a scoping review of the field’s evolution and associated ethical, legal, and social implications. Preprint at SSRN https://doi.org/10.2139/ssrn.5934255 (2025).
Acknowledgements
The authors acknowledge other members of the GA4GH genomic newborn screening working group, in particular A. Pichini, for their input to the policy tool.
Author information
Authors and Affiliations
Consortia
Corresponding author
Ethics declarations
Competing interests
Y.B. is co-founder of Genetics Adviser. The other authors declare no competing interests.
Additional information
Related links
Global Alliance for Genomics and Health: https://www.ga4gh.org/about-us/
GA4GH policy tool: https://www.ga4gh.org/document/genomic-sequencing-in-newborn-screening-policy-tool/
Rights and permissions
About this article
Cite this article
Lewis, A.C.F., Brown, G., The GA4GH Working Group on genomic newborn screening. et al. Navigating ethical, legal and social implications in genomic newborn screening. Nat Rev Genet 27, 265–266 (2026). https://doi.org/10.1038/s41576-026-00936-4
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41576-026-00936-4